Kazia Therapeutics Limited
KZIA
$13.25
$3.1931.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.41M | -16.04M | -18.73M | -18.20M | -17.58M |
| Total Depreciation and Amortization | 617.20K | 925.20K | 1.23M | 1.23M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.08M | 5.25M | 4.47M | 3.99M | 3.50M |
| Change in Net Operating Assets | -1.94M | 1.71M | 5.33M | 5.95M | 6.58M |
| Cash from Operations | -8.64M | -8.16M | -7.70M | -7.02M | -6.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -300.00 | -600.00 | 387.70K | 776.00K |
| Total Debt Repaid | -- | 400.00 | 800.00 | -185.10K | -371.00K |
| Issuance of Common Stock | 13.66M | 12.34M | 11.03M | 8.49M | 5.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.32M | 1.13M | -55.80K | -216.20K | -376.60K |
| Cash from Financing | 10.39M | 8.80M | 7.25M | 5.62M | 3.92M |
| Foreign Exchange rate Adjustments | -7.70K | 61.10K | 129.10K | 69.20K | 8.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | 703.70K | -324.60K | -1.33M | -2.35M |